Your browser doesn't support javascript.
loading
HIV-1 vaccine design through minimizing envelope metastability.
He, Linling; Kumar, Sonu; Allen, Joel D; Huang, Deli; Lin, Xiaohe; Mann, Colin J; Saye-Francisco, Karen L; Copps, Jeffrey; Sarkar, Anita; Blizard, Gabrielle S; Ozorowski, Gabriel; Sok, Devin; Crispin, Max; Ward, Andrew B; Nemazee, David; Burton, Dennis R; Wilson, Ian A; Zhu, Jiang.
Afiliação
  • He L; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Kumar S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Allen JD; International AIDS Vaccine Initiative Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Huang D; Scripps Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Lin X; Centre for Biological Sciences and Institute for Life Sciences, University of Southampton, Highfield Campus, Southampton SO17 1BJ, UK.
  • Mann CJ; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Saye-Francisco KL; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Copps J; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Sarkar A; Scripps Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Blizard GS; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Ozorowski G; Scripps Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Sok D; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Crispin M; International AIDS Vaccine Initiative Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Ward AB; Scripps Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Nemazee D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Burton DR; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Wilson IA; International AIDS Vaccine Initiative Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Zhu J; Scripps Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA.
Sci Adv ; 4(11): eaau6769, 2018 11.
Article em En | MEDLINE | ID: mdl-30474059

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Proteína gp41 do Envelope de HIV / Infecções por HIV / HIV-1 / Vacinas contra a AIDS / Produtos do Gene env do Vírus da Imunodeficiência Humana Limite: Animals / Female / Humans Idioma: En Revista: Sci Adv Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Proteína gp41 do Envelope de HIV / Infecções por HIV / HIV-1 / Vacinas contra a AIDS / Produtos do Gene env do Vírus da Imunodeficiência Humana Limite: Animals / Female / Humans Idioma: En Revista: Sci Adv Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos